Privia Health Group, Inc. (PRVA)

Market Cap	3.09B +1.9%
Revenue (ttm)	2.43B +19.2%
Net Income	34.75M +91.3%
EPS	0.26 +85.3%
Shares Out	127.73M
PE Ratio	93.16
Forward PE	57.70
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,131,536
Open	23.94
Previous Close	23.94
Day's Range	23.66 - 24.33
52-Week Range	18.92 - 28.82
Beta	0.75
Analysts	Strong Buy
Price Target	31.47 (+30.15%)
Earnings Date	Nov 5, 2026

About PRVA

Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with physician practices, health plans, and health systems. It also offers technology and population health tools to enhance providers’ workflows; management services organization that enable providers to focus on their patients by reducing administrative work; and single-TIN medical group that facilitates negotiating power, clinical integration, and alignment of financial incentives. In addition, the company operates acc...

• Industry: Health Information Services
• Sector: Healthcare
• IPO Date: Apr 29, 2021
• Employees: 1,226
• Stock Exchange: Nasdaq
• Ticker Symbol: PRVA
• Website: https://www.priviahealth.com

Financial Performance

In 2025, Privia Health Group's revenue was $2.12 billion, an increase of 22.26% compared to the previous year's $1.74 billion. Earnings were $22.92 million, an increase of 59.33%.

Analyst Summary

According to 18 analysts, the average rating for PRVA stock is "Strong Buy." The 12-month stock price target is $31.47, which is an increase of 30.15% from the latest price.

Price Target

$31.47

(30.15% upside)

Analyst Consensus: Strong Buy

Data Sources: S&P Global Market Intelligence, CBOE, and more

Fundamental and historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP.

Last checked:

Nov 6, 2026

Data Sources Report a data error